Special Survey for Paediatric Subjects

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01487382

Enrollment

241

Registered

2011-12-07

Start date

2002-04-30

Completion date

2009-10-31

Last updated

2016-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Brief summary

This study is conducted in Japan. The aim of this study is to collect safety and efficacy data when using NovoRapid® (insulin aspart) in children with type 1 and type 2 diabetes under normal clinical practice conditions.

Interventions

DRUGinsulin aspart

Injected subcutaneously (s.c., under the skin). Prescribed by physician as a result of normal clinical practice

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 15 Years

Healthy volunteers

Inclusion criteria

* Requiring insulin therapy * No treatment history of NovoRapid® (insulin aspart)

Design outcomes

Primary

Measure	Time frame
Hypoglycaemic events	—

Secondary

Measure	Time frame
HbA1c (glycosylated haemoglobin)	—
Physicial examination	—
Adverse events	—

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026